As of 2026-10-06, the Relative Valuation of Design Therapeutics Inc (DSGN) is (28.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.34 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -334.2%.
The range of the Relative Valuation is (28.22) - (28.34) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 29.1x | 27.0x |
| Forward P/E multiples | 23.0x - 25.0x | 24.0x |
| Fair Price | (28.22) - (28.34) | (28.90) |
| Upside | -328.7% - -329.6% | -334.2% |
| Date | P/E |
| 2026-10-02 | -10.89 |
| 2026-10-01 | -10.80 |
| 2026-09-30 | -11.09 |
| 2026-09-29 | -11.13 |
| 2026-09-28 | -10.90 |
| 2026-09-25 | -10.69 |
| 2026-09-24 | -10.80 |
| 2026-09-23 | -10.90 |
| 2026-09-22 | -11.61 |
| 2026-09-21 | -11.07 |
| 2026-09-18 | -10.80 |
| 2026-09-17 | -11.30 |
| 2026-09-16 | -11.03 |
| 2026-09-15 | -10.79 |
| 2026-09-14 | -11.93 |
| 2026-09-11 | -12.91 |
| 2026-09-10 | -13.06 |
| 2026-09-09 | -13.25 |
| 2026-09-08 | -13.44 |
| 2026-09-04 | -13.36 |
| 2026-09-03 | -13.26 |
| 2026-09-02 | -13.70 |
| 2026-09-01 | -13.36 |
| 2026-08-31 | -13.31 |
| 2026-08-28 | -13.33 |
| 2026-08-27 | -13.45 |
| 2026-08-26 | -13.75 |
| 2026-08-25 | -13.83 |
| 2026-08-24 | -13.44 |
| 2026-08-21 | -13.23 |
| 2026-08-20 | -13.73 |
| 2026-08-19 | -14.06 |
| 2026-08-18 | -13.47 |
| 2026-08-17 | -13.32 |
| 2026-08-14 | -13.08 |
| 2026-08-13 | -12.70 |
| 2026-08-12 | -12.93 |
| 2026-08-11 | -12.90 |
| 2026-08-10 | -12.64 |
| 2026-08-07 | -12.34 |
| 2026-08-06 | -12.15 |
| 2026-08-05 | -11.97 |
| 2026-08-04 | -11.65 |
| 2026-08-03 | -11.26 |
| 2026-07-31 | -10.75 |
| 2026-07-30 | -11.13 |
| 2026-07-29 | -10.60 |
| 2026-07-28 | -10.47 |
| 2026-07-27 | -10.48 |
| 2026-07-24 | -10.39 |